Literature DB >> 14618256

Human MutY: gene structure, protein functions and interactions, and role in carcinogenesis.

A R Parker1, J R Eshleman.   

Abstract

Faithful maintenance of the genome is crucial to the individual and the species. Oxidative DNA damage, such as 8-oxo-7,8-dihydroguanine (8-oxoG), poses a major threat to genomic integrity. 8-OxoG can mispair with 2'-deoxycytidine 5'-triphosphate or with 2'-deoxyadenosine triphosphate during DNA replication, forming C*8-oxoG and A*8-oxoG mispairs. Human MutY is responsible for recognition and removal of the inappropriately inserted adenine in an A*8-oxoG mispair. If unrepaired, the A*8-oxoG mispairs can result in deleterious C:G to A:T transversions. Human MutY functions in a postreplication repair pathway and is targeted to the newly synthesized daughter strand of DNA for removal of the adenine base. The human MutY protein is targeted to both the mitochondria and the nucleus and associates with the proliferating cell nuclear antigen, apurinic/ apyrimidinic endonuclease 1, replication protein A and mutS homolog 6 proteins. Mutations in the human MutY gene and defective activity of the human MutY protein have been detected in cancer. A direct correlation between defective A*8-oxoG repair and increased levels of genomic 8-oxoG has now been established.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14618256     DOI: 10.1007/s00018-003-3053-4

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  23 in total

1.  Ser 524 is a phosphorylation site in MUTYH and Ser 524 mutations alter 8-oxoguanine (OG): a mismatch recognition.

Authors:  Sucharita Kundu; Megan K Brinkmeyer; Richard A Eigenheer; Sheila S David
Journal:  DNA Repair (Amst)       Date:  2010-08-17

2.  Distinct functional consequences of MUTYH variants associated with colorectal cancer: Damaged DNA affinity, glycosylase activity and interaction with PCNA and Hus1.

Authors:  Megan K Brinkmeyer; Sheila S David
Journal:  DNA Repair (Amst)       Date:  2015-08-12

Review 3.  Repair of 8-oxoG:A mismatches by the MUTYH glycosylase: Mechanism, metals and medicine.

Authors:  Douglas M Banda; Nicole N Nuñez; Michael A Burnside; Katie M Bradshaw; Sheila S David
Journal:  Free Radic Biol Med       Date:  2017-01-10       Impact factor: 7.376

4.  Immunohistochemistry is not an accurate first step towards the molecular diagnosis of MUTYH-associated polyposis.

Authors:  Rachel S van der Post; Carolien M Kets; Marjolijn J L Ligtenberg; Joannes H J M van Krieken; Nicoline Hoogerbrugge
Journal:  Virchows Arch       Date:  2008-11-25       Impact factor: 4.064

5.  8-Oxo-2'-deoxyguanosine as a biomarker of tobacco-smoking-induced oxidative stress.

Authors:  Clementina Mesaros; Jasbir S Arora; Ashley Wholer; Anil Vachani; Ian A Blair
Journal:  Free Radic Biol Med       Date:  2012-05-18       Impact factor: 7.376

6.  Genomic predictors of interindividual differences in response to DNA damaging agents.

Authors:  Rebecca C Fry; J Peter Svensson; Chandni Valiathan; Emma Wang; Brad J Hogan; Sanchita Bhattacharya; James M Bugni; Charles A Whittaker; Leona D Samson
Journal:  Genes Dev       Date:  2008-09-19       Impact factor: 11.361

7.  Adenine removal activity and bacterial complementation with the human MutY homologue (MUTYH) and Y165C, G382D, P391L and Q324R variants associated with colorectal cancer.

Authors:  Sucharita Kundu; Megan K Brinkmeyer; Alison L Livingston; Sheila S David
Journal:  DNA Repair (Amst)       Date:  2009-12-03

Review 8.  DNA repair of oxidative DNA damage in human carcinogenesis: potential application for cancer risk assessment and prevention.

Authors:  Tamar Paz-Elizur; Ziv Sevilya; Yael Leitner-Dagan; Dalia Elinger; Laila C Roisman; Zvi Livneh
Journal:  Cancer Lett       Date:  2008-04-18       Impact factor: 8.679

9.  MUTYH Associated Polyposis (MAP).

Authors:  M L M Poulsen; M L Bisgaard
Journal:  Curr Genomics       Date:  2008-09       Impact factor: 2.236

10.  Base excision repair and the role of MUTYH.

Authors:  Carla Kairupan; Rodney J Scott
Journal:  Hered Cancer Clin Pract       Date:  2007-12-15       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.